Ancora Heart Inc. Company Profile

08:58 EDT 22nd July 2018 | BioPortfolio

Ancora Heart, Inc., based in Santa Clara, Calif., is dedicated to helping people with heart failure feel better and live longer. Ancora Heart developed the AccuCinch System, an investigational therapy designed to repair the enlarged left ventricle targeting the underlying cause of heart failure. The AccuCinch heart failure treatment was created to benefit the millions of patients who otherwise have no minimally invasive option available to them. For more information visit

News Articles [1368 Associated News Articles listed on BioPortfolio]

Ancora Heart raises $17.8m funding for heart failure therapy

US-based Ancora Heart has raised $17.8m financingto support continued clinical assessment of its AccuCinch ventricular repair system.

Funding round pulls in $17.8M for Ancora Heart

A round of financing brought in $17.8 million for Santa Clara, Calif.-based Ancora Heart, bringing the company closer to its  -More- 

Ancora Heart gets $17.8mm in first tranche of late-stage financing

Cardiovascular device maker Ancora Heart Inc. raised $17.8mm in an initial tranche of a late-stage financing that could bring in $30mm. Savitr Capital led and was joined by other returning backers. Ac...

Ancora Heart expands US feasibility study to evaluate ventricular repair system

Ancora Heart has expanded enrollment of US early feasibility study for the AccuCinch System for left ventricular repair.

Ancora Heart Announces $17.8 Million Financing for First-of-Its-Kind Therapy for Systolic Heart Failure

– Funds Will Support Continued Clinical Evaluation of the AccuCinch Left Ventricular Repair System – Ancora Heart, Inc., a company developing a novel therapy to address ...

Ancora Heart Expands Enrollment of U.S. Early Feasibility Study for the AccuCinch System for Left Ventricular Repair

Study Evaluates Safety of First-of-Its-Kind Therapy Designed to Directly Target Systolic Heart Failure Ancora Heart, Inc., a company developing a novel therapy to address ...

Study of ventricular repair system expanded by Ancora Health

Enrollment for a feasibility study of the AccuCinch left ventricular repair system was expanded by Ancora Health after FDA ap -More- 

Heart defects in infant may predict heart problems in birth mother later in life

(American Heart Association) Women who give birth to infants with congenital heart defects may be at increased risk of heart problems including heart attack and heart failure later in life.

PubMed Articles [2056 Associated PubMed Articles listed on BioPortfolio]

Determinants of Heart Rate Variability in the General Population: The Lifelines Cohort Study Determinants of Heart Rate Variability.

Heart rate variability (HRV) is an important marker of heart health with low values reflecting reduced vagal control of the heart rhythm.

An East-West comparison of self-care barriers in heart failure.

Barriers in heart failure self-care contribute to heart failure hospitalizations, but geographic differences have not been well-studied. We aimed to compare self-care barriers in heart failure patient...

A rare case of metastatic tumor of heart from bludder cancer.

The article presents a case report of metastatic heart damage which developed in association with urothelial bladder carcinoma in a 79-year old female patient. Various masses may be found in the heart...

Heart Rate, Beta Blocker Use, and Outcomes of Heart Failure with Reduced Ejection Fraction.

High resting heart rate (HR; ≥70 beats/minute) is associated with worse clinical outcomes in heart failure with reduced ejection fraction (HFrEF).

Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: Executive Summary of a Joint Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, Endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pac

Clinical Trials [3778 Associated Clinical Trials listed on BioPortfolio]

Curing Atrial Fibrillation in Heart Failure

Heart failure is a condition that occurs when the heart muscle weakens and no longer contracts normally. Half of these patients have an irregularity of heart rhythm called atrial fibrilla...

A Partnership to Translate an Evidence-based Intervention (Take Heart) for Vulnerable Older Adults With Heart Disease

To evaluate the effectiveness of Take Heart, a behavioral/educational program for adults age 50+ with heart disease, or with at least two risk factors for heart disease, that helps them to...

“ALOFT – Aliskiren Observation of Heart Failure Treatment”: Efficacy and Safety of Aliskiren Added on Top of Standard Therapy in Adults (≥ 18 Years) With Stable Heart Failure

This study was designed to determine if patients, who have both high blood pressure and heart failure and are currently receiving drug treatment for heart failure, have an improvement in t...

Heart Failure in Adult Patients With a History of Congenital Heart Disease

In today's world of advanced surgery, children born with congenital heart disease (CHD) are surviving into adulthood. However, the surgical procedures these children undergo do not cure th...

Attain Model 4196 Left Ventricular (LV) Lead

Heart failure is a progressive disease that decreases the pumping action of the heart. This may cause a backup of fluid in the heart and may result in heart beat changes. When there are ch...

Companies [696 Associated Companies listed on BioPortfolio]

Ancora Heart, Inc.

Ancora Heart, Inc., based in Santa Clara, Calif., is dedicated to helping people with heart failure feel better and live longer. Ancora Heart developed the AccuCinch System, an in...

Ancora Heart Inc.

Ancora Heart, Inc., based in Santa Clara, Calif., is dedicated to helping people with heart failure feel better and live longer. Ancora Heart developed the AccuCinch System, an in...

Ancora Pharmaceuticals Inc.

Ancora’s cutting edge technology enables the rapid, milligram to kilogram production of synthetic carbohydrates for use in drug discovery and industrial applications.


IPS HEART is a privately-held biopharmaceutical company dedicated to addressing heart attack, heart failure and duchenne cardiomyopathy via next generation cellular therapy. IPS H...

Sunshine Heart

Heart failure is a common condition in which the heart becomes unable to pump sufficient blood to meet the body's needs. Over five million people in the United States have heart failure and it results...

More Information about "Ancora Heart Inc." on BioPortfolio

We have published hundreds of Ancora Heart Inc. news stories on BioPortfolio along with dozens of Ancora Heart Inc. Clinical Trials and PubMed Articles about Ancora Heart Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ancora Heart Inc. Companies in our database. You can also find out about relevant Ancora Heart Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topics

Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...

Corporate Database Quicklinks

Searches Linking to this Company Record